226 related articles for article (PubMed ID: 32033248)
1. A Dietary Ketone Ester Normalizes Abnormal Behavior in a Mouse Model of Alzheimer's Disease.
Pawlosky RJ; Kashiwaya Y; King MT; Veech RL
Int J Mol Sci; 2020 Feb; 21(3):. PubMed ID: 32033248
[TBL] [Abstract][Full Text] [Related]
2. Effects of a dietary ketone ester on hippocampal glycolytic and tricarboxylic acid cycle intermediates and amino acids in a 3xTgAD mouse model of Alzheimer's disease.
Pawlosky RJ; Kemper MF; Kashiwaya Y; King MT; Mattson MP; Veech RL
J Neurochem; 2017 Apr; 141(2):195-207. PubMed ID: 28099989
[TBL] [Abstract][Full Text] [Related]
3. Ingested Ketone Ester Leads to a Rapid Rise of Acetyl-CoA and Competes with Glucose Metabolism in the Brain of Non-Fasted Mice.
Suissa L; Kotchetkov P; Guigonis JM; Doche E; Osman O; Pourcher T; Lindenthal S
Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33430235
[TBL] [Abstract][Full Text] [Related]
4. Brain amino acid metabolism and ketosis.
Yudkoff M; Daikhin Y; Nissim I; Lazarow A; Nissim I
J Neurosci Res; 2001 Oct; 66(2):272-81. PubMed ID: 11592124
[TBL] [Abstract][Full Text] [Related]
5. Dysfunctional TCA-Cycle Metabolism in Glutamate Dehydrogenase Deficient Astrocytes.
Nissen JD; Pajęcka K; Stridh MH; Skytt DM; Waagepetersen HS
Glia; 2015 Dec; 63(12):2313-26. PubMed ID: 26221781
[TBL] [Abstract][Full Text] [Related]
6. Chronic ketosis and cerebral metabolism.
DeVivo DC; Leckie MP; Ferrendelli JS; McDougal DB
Ann Neurol; 1978 Apr; 3(4):331-37. PubMed ID: 666275
[TBL] [Abstract][Full Text] [Related]
7. Response of brain amino acid metabolism to ketosis.
Yudkoff M; Daikhin Y; Nissim I; Horyn O; Lazarow A; Luhovyy B; Wehrli S; Nissim I
Neurochem Int; 2005 Jul; 47(1-2):119-28. PubMed ID: 15888376
[TBL] [Abstract][Full Text] [Related]
8. Ketone Ester Effects on Biomarkers of Brain Metabolism and Cognitive Performance in Cognitively Intact Adults ≥ 55 Years Old. A Study Protocol for a Double-Blinded Randomized Controlled Clinical Trial.
Avgerinos KI; Mullins RJ; Egan JM; Kapogiannis D
J Prev Alzheimers Dis; 2022; 9(1):54-66. PubMed ID: 35098974
[TBL] [Abstract][Full Text] [Related]
9. Early decline in glucose transport and metabolism precedes shift to ketogenic system in female aging and Alzheimer's mouse brain: implication for bioenergetic intervention.
Ding F; Yao J; Rettberg JR; Chen S; Brinton RD
PLoS One; 2013; 8(11):e79977. PubMed ID: 24244584
[TBL] [Abstract][Full Text] [Related]
10. Ketogenic diet, brain glutamate metabolism and seizure control.
Yudkoff M; Daikhin Y; Nissim I; Lazarow A; Nissim I
Prostaglandins Leukot Essent Fatty Acids; 2004 Mar; 70(3):277-85. PubMed ID: 14769486
[TBL] [Abstract][Full Text] [Related]
11. Cortical substrate oxidation during hyperketonemia in the fasted anesthetized rat in vivo.
Jiang L; Mason GF; Rothman DL; de Graaf RA; Behar KL
J Cereb Blood Flow Metab; 2011 Dec; 31(12):2313-23. PubMed ID: 21731032
[TBL] [Abstract][Full Text] [Related]
12. White Matter Lipids as a Ketogenic Fuel Supply in Aging Female Brain: Implications for Alzheimer's Disease.
Klosinski LP; Yao J; Yin F; Fonteh AN; Harrington MG; Christensen TA; Trushina E; Brinton RD
EBioMedicine; 2015 Dec; 2(12):1888-904. PubMed ID: 26844268
[TBL] [Abstract][Full Text] [Related]
13. Can ketones compensate for deteriorating brain glucose uptake during aging? Implications for the risk and treatment of Alzheimer's disease.
Cunnane SC; Courchesne-Loyer A; St-Pierre V; Vandenberghe C; Pierotti T; Fortier M; Croteau E; Castellano CA
Ann N Y Acad Sci; 2016 Mar; 1367(1):12-20. PubMed ID: 26766547
[TBL] [Abstract][Full Text] [Related]
14. A ketone ester diet exhibits anxiolytic and cognition-sparing properties, and lessens amyloid and tau pathologies in a mouse model of Alzheimer's disease.
Kashiwaya Y; Bergman C; Lee JH; Wan R; King MT; Mughal MR; Okun E; Clarke K; Mattson MP; Veech RL
Neurobiol Aging; 2013 Jun; 34(6):1530-9. PubMed ID: 23276384
[TBL] [Abstract][Full Text] [Related]
15. Novel ketone body therapy for managing Alzheimer's disease: An Editorial Highlight for Effects of a dietary ketone ester on hippocampal glycolytic and tricarboxylic acid cycle intermediates and amino acids in a 3xTgAD mouse model of Alzheimer's disease.
Puchowicz MA; Seyfried TN
J Neurochem; 2017 Apr; 141(2):162-164. PubMed ID: 28299805
[TBL] [Abstract][Full Text] [Related]
16. Neuronal-glial interactions in rats fed a ketogenic diet.
Melø TM; Nehlig A; Sonnewald U
Neurochem Int; 2006; 48(6-7):498-507. PubMed ID: 16542760
[TBL] [Abstract][Full Text] [Related]
17. Availability of neurotransmitter glutamate is diminished when beta-hydroxybutyrate replaces glucose in cultured neurons.
Lund TM; Risa O; Sonnewald U; Schousboe A; Waagepetersen HS
J Neurochem; 2009 Jul; 110(1):80-91. PubMed ID: 19457063
[TBL] [Abstract][Full Text] [Related]
18. Simultaneous determination of the rates of the TCA cycle, glucose utilization, alpha-ketoglutarate/glutamate exchange, and glutamine synthesis in human brain by NMR.
Mason GF; Gruetter R; Rothman DL; Behar KL; Shulman RG; Novotny EJ
J Cereb Blood Flow Metab; 1995 Jan; 15(1):12-25. PubMed ID: 7798329
[TBL] [Abstract][Full Text] [Related]
19. Ketone bodies and brain glutamate and GABA metabolism.
Daikhin Y; Yudkoff M
Dev Neurosci; 1998; 20(4-5):358-64. PubMed ID: 9778572
[TBL] [Abstract][Full Text] [Related]
20. ¹H- and ¹³C-NMR spectroscopy of Thy-1-APPSL mice brain extracts indicates metabolic changes in Alzheimer's disease.
Doert A; Pilatus U; Zanella F; Müller WE; Eckert GP
J Neural Transm (Vienna); 2015 Apr; 122(4):541-50. PubMed ID: 25742870
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
